腱鞘炎治療の世界市場レポート 2025年

腱鞘炎治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.1％で2,791億7,000万米ドルに成長します。予測期間の成長は、政府の支援と資金提供、個別化医療、再生療法の拡大、非侵襲的治療への需要の高まり、遠隔モニタリングと遠隔医療に起因すると考えられます。予測期間の主な動向には、研究開発、再生療法、理学療法の進歩、低侵襲治療への注力、遠隔診察のための遠隔医療などがあります。

スポーツ傷害の増加は、今後の腱鞘炎治療市場の成長を牽引すると予測されます。スポーツ傷害とは、スポーツや身体活動中に受ける傷害や外傷を指し、筋肉、腱、靭帯、骨、関節などに影響を及ぼします。スポーツ傷害に関連する腱炎の治療には、一般的に、損傷した腱の回復を促進し、腫れを抑え、患部を支えるために、安静、疼痛管理、理学療法を組み合わせて行う。例えば、2024年7月、オーストラリアの政府機関であるオーストラリア保健福祉研究所（Australian Institute of Health and Welfare）は、2022年、負傷率が最も高かったのは屋外のチームスポーツで、参加者の約26％が影響を受けたと報告しました。コンバットスポーツは16%の負傷率で僅差で続き、インドアチームスポーツ、モータースポーツ、乗馬スポーツはそれぞれ約15%の参加者が負傷していた（ASC, 2023）。このように、スポーツ傷害の有病率の上昇が、腱鞘炎治療市場の成長に拍車をかけています。

世界の老人人口の増加は、腱鞘炎治療市場の成長に貢献すると予想されます。一般的に65歳以上の老年人口は、腱炎の発生率が増加しており、高齢者特有のニーズに対応した高度で効果的な治療アプローチが必要とされています。2022年10月に世界保健機関（WHO）が報告したように、世界の60歳人口は2020年の10億人に対し、2030年には14億人に達すると予測されています。さらに、2030年には世界の6人に1人が60歳以上になると推定されています。したがって、世界の老年人口の増加が腱鞘炎治療市場の成長を牽引する構えです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界腱鞘炎治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の腱鞘炎治療市場：成長率分析
• 世界の腱鞘炎治療市場の実績：規模と成長, 2019-2024
• 世界の腱鞘炎治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界腱鞘炎治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の腱鞘炎治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 治療的治療
• 温冷療法
• 理学療法
• 衝撃波療法
• 外科的治療
• 世界の腱鞘炎治療市場症状タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• テニス肘
• ゴルフ肘
• 投手の肘
• ジャンパー膝
• スイマーズショルダー
• アキレス腱炎
• 世界の腱鞘炎治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 在宅ヘルスケア
• その他のエンドユーザー
• 世界の腱鞘炎治療市場、治療治療のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非ステロイド性抗炎症薬（NSAID）
• コルチコステロイド注射
• 多血小板血漿（PRP）療法
• 世界の腱鞘炎治療市場温熱療法と冷却療法の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒートパック
• アイスパック
• コントラスト療法
• 世界の腱鞘炎治療市場、理学療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ストレッチ運動
• 筋力強化エクササイズ
• 手技療法
• 世界の腱鞘炎治療市場、衝撃波療法の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 放射状衝撃波療法
• 集中衝撃波療法
• 世界の腱鞘炎治療市場、外科的治療のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腱修復手術
• 腱切開術
• 関節鏡検査

第7章 地域別・国別分析

• 世界の腱鞘炎治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の腱鞘炎治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腱鞘炎治療市場：競合情勢
• 腱鞘炎治療市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Almatica Pharma Inc.
• Teva Pharmaceutical Industries Ltd.
• Smith & Nephew plc
• Stryker Corporation
• Zimmer Biomet Holdings Inc.
• Ossur hf
• Tynor India Ltd.
• Arthrex Inc.
• CONMED Corporation
• TendoMed Inc.
• BioPro Inc.
• Aevumed Inc.
• Alafair Biosciences Inc.
• AstraZeneca plc
• GlaxoSmithKline plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 腱鞘炎治療市場2029：新たな機会を提供する国
• 腱鞘炎治療市場2029：新たな機会を提供するセグメント
• 腱鞘炎治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Tendonitis treatment involves methods aimed at reducing inflammation in the tissue that connects muscles and bones, known as tendons. The goal is to apply various therapies that restore strength and flexibility to the affected tendons, alleviating inflammation and pain in the affected area.

The primary types of tendonitis treatments include rest, hot and cold therapy, physical therapy, shockwave therapy, and surgical interventions. Therapeutic therapy encompasses a diverse range of processes focused on promoting healing and addressing specific issues. In tendonitis treatment, therapeutic therapy includes various interventions such as steroids, surgery, and physical therapies to diminish inflammation and alleviate pain. Common types of tendonitis conditions include tennis elbow, golfer's elbow, pitcher's elbow, jumper's knee, swimmer's shoulder, and Achilles tendonitis. These treatments are utilized across different end-users, including hospitals, specialty clinics, home healthcare, and others.

The tendonitis treatment market research report is one of a series of new reports from The Business Research Company that provides tendonitis treatment market statistics, including tendonitis treatment industry global market size, regional shares, competitors with a tendonitis treatment market share, detailed tendonitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the tendonitis treatment industry. This tendonitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tendonitis treatment market size has grown steadily in recent years. It will grow from$221.21 billion in 2024 to $228.79 billion in 2025 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to pharmaceutical developments, increased sports injuries, aging population, occupational factors, awareness and education

The tendonitis treatment market size is expected to see strong growth in the next few years. It will grow to $279.17 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to government support and funding, personalized medicine, expansion of regenerative therapies, rise in demand for non-invasive treatments, remote monitoring and telehealth. Major trends in the forecast period include research and development, regenerative therapies, advancements in physical therapy, focus on minimally invasive treatments, telemedicine for remote consultations.

The increasing occurrence of sports injuries is anticipated to drive the growth of the tendonitis treatment market in the future. A sports injury refers to any injury or trauma sustained during sports or physical activities, affecting muscles, tendons, ligaments, bones, and joints. Treatment for tendonitis related to sports injuries typically involves a combination of rest, pain management, and physical therapy to promote recovery of the injured tendon, reduce swelling, and support the affected area. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that in 2022, the highest injury rate was found in outdoor team sports, impacting approximately 26% of participants. Combat sports followed closely with a 16% injury rate, while indoor team sports, motor sports, and equestrian sports each had around 15% of participants injured (ASC, 2023). Thus, the rising prevalence of sports injuries is fueling the growth of the tendonitis treatment market.

The rise in the global geriatric population is expected to contribute to the growth of the tendonitis treatment market. The geriatric population, typically aged 65 years or older, is witnessing an increasing incidence of tendonitis, necessitating advanced and effective treatment approaches tailored to address the specific needs of older individuals. As reported by the World Health Organization in October 2022, the global population of individuals aged 60 years is projected to reach 1.4 billion by 2030, compared to 1 billion in 2020. Moreover, it is estimated that 1 out of 6 people worldwide will be aged 60 years or older by 2030. Therefore, the growing global geriatric population is poised to drive the growth of the tendonitis treatment market.

Major companies in the tendonitis treatment market are concentrating on developing technologically advanced solutions, such as stem cell therapies, to enhance healing and shorten recovery times for patients. Stem cell therapies utilize stem cells to promote healing and repair damaged tissues in the body. These treatments harness the regenerative capabilities of stem cells to address various conditions, including tendonitis, by improving tissue regeneration and reducing inflammation. For example, in April 2022, C.H. Boehringer Sohn AG & Co. KG, a pharmaceutical company based in Germany, launched RenuTend to improve the healing of tendon and suspensory ligament injuries in horses. RenuTend is a targeted stem cell therapy designed to enhance tendon healing by promoting parallel fiber alignment and minimizing scar tissue formation, which is vital for preventing reinjury in horses. Administered through intralesional injection, this innovative treatment demonstrates proven efficacy and consistent results, representing a significant advancement in equine veterinary medicine.

Major players in the tendonitis treatment market are intensifying their focus on introducing innovative implants, such as bioinductive implants, to gain a competitive advantage. Bioinductive implants stimulate the body's natural healing processes by providing a scaffold that promotes tissue regeneration. In July 2023, Smith & Nephew plc launched the REGENETEN bioinductive implant in India for rotator cuff repair. This implant supports the body's natural healing response, facilitating new tendon-such as tissue growth and altering the course of rotator cuff disease. Comprised of type 1 collagen, the implant offers an advanced healing solution for biological tendon regeneration across the spectrum of rotator cuff disease. About the size of a postage stamp, the implant is delivered arthroscopically through a small incision and disappears within six months, inducing the growth of new tendon-such as tissue and collagen orientation indicative of functional loading.

In April 2023, Vander-Bend Manufacturing, Inc., a US-based medical technology company, acquired Omni Components Corporation for an undisclosed amount. This acquisition is aimed at expanding Vander-Bend Manufacturing's manufacturing capabilities in the Northeast and Southwest. Omni Components Corporation is a US-based manufacturer and service provider of medical products specializing in spinal, cardiovascular, and tendon-related surgeries.

Major companies operating in the tendonitis treatment market include Merck & Co. Inc., Bayer AG, Boehringer Ingelheim GmbH, Abbott Laboratories, Pfizer Inc., Almatica Pharma Inc., Teva Pharmaceutical Industries Ltd., Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Ossur hf, Tynor India Ltd., Arthrex Inc., CONMED Corporation, TendoMed Inc., BioPro Inc., Aevumed Inc., Alafair Biosciences Inc., AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, Wright Medical Group N.V., Breg Inc., Mueller Sports Medicine Inc., Bauerfeind AG, BSN medical GmbH, Henry Schein Inc.

North America was the largest region in the tendonitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global tendonitis treatment market report during the forecast period. The regions covered in the tendonitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tendonitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tendonitis treatment market includes revenues earned by entities by providing various treatment to relieve pain and reduce irritation in tendinitis such as pain relivers, steroids, platelet rich-plasma, dry needling, compression and elevation, bracing and splinting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tendonitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tendonitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tendonitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tendonitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Therapeutic Treatment; Hot And Cold Therapy; Physical Therapy; Shockwave Therapy; Surgical Treatment
• 2) By Condition Type: Tennis Elbow; Golfer's Elbow; Pitcher's Elbow; Jumper's Knee; Swimmer's Shoulder; Achilles Tendonitis
• 3) By End-Users: Hospitals; Specialty Clinics; Home Healthcare; Other End-Users
• Subsegments:
• 1) By Therapeutic Treatment: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroid Injections; Platelet-Rich Plasma (PRP) Therapy
• 2) By Hot And Cold Therapy: Heat Packs; Ice Packs; Contrast Therapy
• 3) By Physical Therapy: Stretching Exercises; Strengthening Exercises; Manual Therapy
• 4) By Shockwave Therapy: Radial Shockwave Therapy; Focused Shockwave Therapy
• 5) By Surgical Treatment: Tendon Repair Surgery; Tenotomy; Arthroscopy
• Companies Mentioned: Merck & Co. Inc.; Bayer AG; Boehringer Ingelheim GmbH; Abbott Laboratories; Pfizer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tendonitis Treatment Market Characteristics

3. Tendonitis Treatment Market Trends And Strategies

4. Tendonitis Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Tendonitis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tendonitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tendonitis Treatment Market Growth Rate Analysis
• 5.4. Global Tendonitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tendonitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tendonitis Treatment Total Addressable Market (TAM)

6. Tendonitis Treatment Market Segmentation

• 6.1. Global Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic Treatment
• Hot And Cold Therapy
• Physical Therapy
• Shockwave Therapy
• Surgical Treatment
• 6.2. Global Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tennis Elbow
• Golfer's Elbow
• Pitcher's Elbow
• Jumper's Knee
• Swimmer's Shoulder
• Achilles Tendonitis
• 6.3. Global Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Home Healthcare
• Other End-Users
• 6.4. Global Tendonitis Treatment Market, Sub-Segmentation Of Therapeutic Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Corticosteroid Injections
• Platelet-Rich Plasma (PRP) Therapy
• 6.5. Global Tendonitis Treatment Market, Sub-Segmentation Of Hot And Cold Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Heat Packs
• Ice Packs
• Contrast Therapy
• 6.6. Global Tendonitis Treatment Market, Sub-Segmentation Of Physical Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stretching Exercises
• Strengthening Exercises
• Manual Therapy
• 6.7. Global Tendonitis Treatment Market, Sub-Segmentation Of Shockwave Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radial Shockwave Therapy
• Focused Shockwave Therapy
• 6.8. Global Tendonitis Treatment Market, Sub-Segmentation Of Surgical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tendon Repair Surgery
• Tenotomy
• Arthroscopy

7. Tendonitis Treatment Market Regional And Country Analysis

• 7.1. Global Tendonitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tendonitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tendonitis Treatment Market

• 8.1. Asia-Pacific Tendonitis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tendonitis Treatment Market

• 9.1. China Tendonitis Treatment Market Overview
• 9.2. China Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tendonitis Treatment Market

• 10.1. India Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tendonitis Treatment Market

• 11.1. Japan Tendonitis Treatment Market Overview
• 11.2. Japan Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tendonitis Treatment Market

• 12.1. Australia Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tendonitis Treatment Market

• 13.1. Indonesia Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tendonitis Treatment Market

• 14.1. South Korea Tendonitis Treatment Market Overview
• 14.2. South Korea Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tendonitis Treatment Market

• 15.1. Western Europe Tendonitis Treatment Market Overview
• 15.2. Western Europe Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tendonitis Treatment Market

• 16.1. UK Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tendonitis Treatment Market

• 17.1. Germany Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tendonitis Treatment Market

• 18.1. France Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tendonitis Treatment Market

• 19.1. Italy Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tendonitis Treatment Market

• 20.1. Spain Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tendonitis Treatment Market

• 21.1. Eastern Europe Tendonitis Treatment Market Overview
• 21.2. Eastern Europe Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tendonitis Treatment Market

• 22.1. Russia Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tendonitis Treatment Market

• 23.1. North America Tendonitis Treatment Market Overview
• 23.2. North America Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tendonitis Treatment Market

• 24.1. USA Tendonitis Treatment Market Overview
• 24.2. USA Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tendonitis Treatment Market

• 25.1. Canada Tendonitis Treatment Market Overview
• 25.2. Canada Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tendonitis Treatment Market

• 26.1. South America Tendonitis Treatment Market Overview
• 26.2. South America Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tendonitis Treatment Market

• 27.1. Brazil Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tendonitis Treatment Market

• 28.1. Middle East Tendonitis Treatment Market Overview
• 28.2. Middle East Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tendonitis Treatment Market

• 29.1. Africa Tendonitis Treatment Market Overview
• 29.2. Africa Tendonitis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tendonitis Treatment Market, Segmentation By Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tendonitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tendonitis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Tendonitis Treatment Market Competitive Landscape
• 30.2. Tendonitis Treatment Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tendonitis Treatment Market Other Major And Innovative Companies

• 31.1. Almatica Pharma Inc.
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Smith & Nephew plc
• 31.4. Stryker Corporation
• 31.5. Zimmer Biomet Holdings Inc.
• 31.6. Ossur hf
• 31.7. Tynor India Ltd.
• 31.8. Arthrex Inc.
• 31.9. CONMED Corporation
• 31.10. TendoMed Inc.
• 31.11. BioPro Inc.
• 31.12. Aevumed Inc.
• 31.13. Alafair Biosciences Inc.
• 31.14. AstraZeneca plc
• 31.15. GlaxoSmithKline plc

32. Global Tendonitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tendonitis Treatment Market

34. Recent Developments In The Tendonitis Treatment Market

35. Tendonitis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Tendonitis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tendonitis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tendonitis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer